ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITOR IN PTS W/ SICKLE CELL NEPHROPATHY

血管紧张素转换酶 (ACE) 抑制剂治疗镰状细胞肾病患者

• 批准号: 6275092
• 负责人: Ronald J Falk
• 金额: $ 1.58万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-12-01 至 1998-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6275092
• 关键词: ACE inhibitors; blood disorder chemotherapy; chemoprevention; chronic renal failure; clinical research; disease /disorder prevention /control; drug screening /evaluation; human subject; human therapy evaluation; kidney disorder chemotherapy; peptidyl dipeptidase A; proteinuria; sickle cell anemia

The purpose of this study is to determine if the use of angiotensin converting enzyme (ACE) inhibitor prevents the development of renal insufficiency and reduces proteinuria in patients with sickle cell nephropathy.

本研究的目的是确定使用血管紧张素 血管紧张素转换酶（ACE）抑制剂可防止肾 减少镰状细胞病患者的蛋白尿 肾病